1. Home
  2. Monthly Archives: September 2021

Monthly Archives: September 2021

BioFactura’s Ustekinumab Biosimilar To Be Trialed As ‘Robotic’ Pill

From Generics Bulletin/Informa Pharma Intelligence By Dean Rudge 14SEP2021 BioFactura, which is already using its ‘StableFast’ technology platform to develop its biosimilar ustekinumab candidate, has allied with fellow US-based biotech Rani Therapeutics to see if the biologic can be formulated into Rani’s proprietary ‘robotic’ pill. <Read Full Article&gt… Continue reading

September 14, 2021 In The News

BioFactura Announces MTA with Rani Therapeutics

Frederick, Maryland, September 9, 2021:  BioFactura Inc. (“BioFactura”), a leading developer of high-value biosimilar and biodefense drugs using its patented StableFast™ platform, announces an agreement with Rani Therapeutics (“Rani”) to assess its Ustekinumab Biosimilar (BFI-751) in combination with Rani’s RaniPill™ platform.  BFI-751 is being developed by BioFactura Australia Pty Ltd, a subsidiary of BioFactura, as a biosimilar … Continue reading

September 9, 2021 Press Releases